Eric P. van der Veer

1.2k citations

22 papers · 673 indexed · h-index 13

Co-authors: Anton Jan van Zonneveld Ton J. Rabelink Ruben G. de Bruin Roel Bijkerk Coen van Solingen Hetty C. de Boer Jacques M.G.J. Duijs Janine M. van Gils
Topics: MicroRNA in disease regulation (4 papers)RNA Research and Splicing (4 papers)Renal and related cancers (3 papers)
Cited by: Cancer Research Nephrology Molecular Biology
Journals: Nucleic Acids Research Biomaterials Scientific Reports
Partner nations: Netherlands United States Australia

In The Last Decade

Eric P. van der Veer

21 papers receiving 670 citations

Peers

Countries citing papers authored by Eric P. van der Veer

Since Specialization

Citations

This map shows the geographic impact of Eric P. van der Veer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric P. van der Veer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric P. van der Veer more than expected).

Fields of papers citing papers by Eric P. van der Veer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric P. van der Veer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric P. van der Veer. The network helps show where Eric P. van der Veer may publish in the future.

Co-authorship network of co-authors of Eric P. van der Veer

This figure shows the co-authorship network connecting the top 25 collaborators of Eric P. van der Veer. A scholar is included among the top collaborators of Eric P. van der Veer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric P. van der Veer. Eric P. van der Veer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	RNA-based therapeutic opportunities for the treatment of kidney diseases 2025 ·Nature Reviews Nephrology ·Jurriën Prins,Annabelle Biscans,Anton Jan van Zonneveld,Kendall S. Frazier,Eric P. van der Veer	0
2	Highly Potent Antisense Oligonucleotides Locked Nucleic Acid Gapmers Targeting the SARS-CoV-2 RNA Genome 2023 ·Nucleic Acid Therapeutics ·Vita Dauksaite,Ali Taş,Falk Wachowius,Anouk Spruit,Martijn J. van Hemert,Eric J. Snijder,Eric P. van der Veer,Anton Jan van Zonneveld	1
3	Prediction Power on Cardiovascular Disease of Neuroimmune Guidance Cues Expression by Peripheral Blood Monocytes Determined by Machine-Learning Methods 2020 ·International Journal of Molecular Sciences ·Huayu Zhang,Obbo W Bredewold,Dianne Vreeken,Jacques M.G.J. Duijs,Hetty C. de Boer,Adriaan O. Kraaijeveld,J. Wouter Jukema,Nico H.J. Pijls,Johannes Waltenberger,Erik A.L. Biessen,Eric P. van der Veer,Anton Jan van Zonneveld,Janine M. van Gils	3
4	Comprehensive analysis of neuronal guidance cue expression regulation during monocyte-to-macrophage differentiation reveals post-transcriptional regulation of semaphorin7A by the RNA-binding protein quaking 2020 ·Innate Immunity ·Huayu Zhang,Jurriën Prins,Dianne Vreeken,(unknown),Ruben G. de Bruin,(unknown),Mieke F. van Essen,Jacques M.G.J. Duijs,Hilde Van Esch,Eric P. van der Veer,Anton Jan van Zonneveld,Janine M. van Gils	4
5	Contribution of bone marrow-derived cells to in situ engineered tissue capsules in a rat model of chronic kidney disease 2018 ·Biomaterials ·(unknown),(unknown),Dong Wang,(unknown),Eric P. van der Veer,(unknown),Febriyani Damanik,Xuefeng Qiu,Anton Jan van Zonneveld,Lorenzo Moroni,Song Li,Joris I. Rotmans	10
6	Relaxin receptor deficiency promotes vascular inflammation and impairs outward remodeling in arteriovenous fistulas 2018 ·The FASEB Journal ·(unknown),Margreet R. de Vries,(unknown),Eric P. van der Veer,Sabine Versteeg,(unknown),(unknown),Niels Eijkelkamp,Koen E.A. van der Bogt,Alexander I. Agoulnik,Anton Jan van Zonneveld,Paul H.A. Quax,Joris I. Rotmans	14
7	No indications for platelet activation in acute clinical myocardial or renal ischemia/reperfusion injury. 2018 ·PubMed ·Kirsten A. Kortekaas,Dorottya K. de Vries,Mark Roest,Marlies E. J. Reinders,Eric P. van der Veer,Robert J.M. Klautz,Philip G. de Groot,Alexander F. Schaapherder,J. Lindeman	3
8	Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia–reperfusion injury in the rat 2017 ·Nephrology Dialysis Transplantation ·(unknown),(unknown),Jurriën Prins,(unknown),Mieke F. van Essen,Jurjen M. Ruben,Alexander L. Vahrmeijer,Eric P. van der Veer,Johan W. de Fijter,Marlies E. J. Reinders,Onno C. Meijer,Josbert M. Metselaar,Cees van Kooten,Joris I. Rotmans	33
9	Deficiency of TLR4 homologue RP105 aggravates outward remodeling in a murine model of arteriovenous fistula failure 2017 ·Scientific Reports ·(unknown),(unknown),Margreet R. de Vries,Eric P. van der Veer,(unknown),Ivo Que,Reshma A. Lalai,Anton Jan van Zonneveld,Joris I. Rotmans,Paul H.A. Quax	20
10	Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women? 2017 ·Cardiovascular Research ·(unknown),Roel Bijkerk,Eric P. van der Veer,Anton Jan van Zonneveld	66
11	Promoting Tropoelastin Expression in Arterial and Venous Vascular Smooth Muscle Cells and Fibroblasts for Vascular Tissue Engineering 2016 ·Tissue Engineering Part C Methods ·T.C. Rothuizen,(unknown),Jacques M.G.J. Duijs,Hetty C. de Boer,Roel Bijkerk,Eric P. van der Veer,Lorenzo Moroni,Anton Jan van Zonneveld,Anthony S. Weiss,Ton J. Rabelink,Joris I. Rotmans	10
12	Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation 2016 ·Kidney International ·Roel Bijkerk,Ruben G. de Bruin,Coen van Solingen,Janine M. van Gils,Jacques M.G.J. Duijs,Eric P. van der Veer,Ton J. Rabelink,Benjamin D. Humphreys,Anton Jan van Zonneveld	94
13	Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease 2016 ·European Heart Journal ·Ruben G. de Bruin,Ton J. Rabelink,Anton Jan van Zonneveld,Eric P. van der Veer	99
14	The RNA-binding protein quaking maintains endothelial barrier function and affects VE-cadherin and β-catenin protein expression 2016 ·Scientific Reports ·Ruben G. de Bruin,Eric P. van der Veer,Jurriën Prins,Dae Hyun Lee,Martijn J. C. Dane,Huayu Zhang,Marko K. Roeten,Roel Bijkerk,Hetty C. de Boer,Ton J. Rabelink,Anton Jan van Zonneveld,Janine M. van Gils	36
15	Modeling the combined effect of RNA-binding proteins and microRNAs in post-transcriptional regulation 2016 ·Nucleic Acids Research ·Saber Hafezqorani,Atefeh Lafzi,Ruben G. de Bruin,Anton Jan van Zonneveld,Eric P. van der Veer,Yeşim Aydın Son,Hilal Kazan	31
16	Silencing of MiRNA-126 in Kidney Ischemia Reperfusion is Associated with Elevated SDF-1 Levels and Mobilization of Sca-1+/Lin- Progenitor Cells 2015 ·MicroRNA ·Roel Bijkerk,Coen van Solingen,Hetty C. de Boer,Dorottya K. de Vries,Matthieu Monge,(unknown),Eric P. van der Veer,Alexander F. Schaapherder,Ton J. Rabelink,Anton Jan van Zonneveld	12
17	Scavenger Receptor-AI–Targeted Iron Oxide Nanoparticles for In Vivo MRI Detection of Atherosclerotic Lesions 2013 ·Arteriosclerosis Thrombosis and Vascular Biology ·Filip M. Segers,Brigit den Adel,Ilze Bot,Linda M. van der Graaf,Eric P. van der Veer,Walter G. Gonzalez,Isabelle Raynal,Menno P.J. de Winther,Will K. W. H. Wodzig,Robert E. Poelmann,Theo J.C. van Berkel,Louise van der Weerd,Erik A.L. Biessen	53
18	MicroRNA-155 Functions as a Negative Regulator of RhoA Signaling in TGF-β-induced Endothelial to Mesenchymal Transition 2012 ·MicroRNA ·Roel Bijkerk,Ruben G. de Bruin,Coen van Solingen,Jacques M.G.J. Duijs,Kyousuke Kobayashi,Eric P. van der Veer,Peter ten Dijke,Ton J. Rabelink,Marie‐José Goumans,Anton Jan van Zonneveld	45
19	MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1+/Lin− progenitor cells in ischaemia 2011 ·Cardiovascular Research ·Coen van Solingen,Hetty C. de Boer,Roel Bijkerk,Matthieu Monge,Annemarie M. van Oeveren‐Rietdijk,Leonard Seghers,Margreet R. de Vries,Eric P. van der Veer,Paul H.A. Quax,Ton J. Rabelink,Anton Jan van Zonneveld	69
20	Inflammation, vascular injury and repair in rheumatoid arthritis 2009 ·Annals of the Rheumatic Diseases ·Anton Jan van Zonneveld,Hetty C. de Boer,Eric P. van der Veer,Ton J. Rabelink	43

About Eric P. van der Veer

Eric P. van der Veer is a scholar working on Cancer Research, Nephrology and Developmental Neuroscience, having authored 22 papers that have together received 673 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), RNA Research and Splicing (4 papers) and Renal and related cancers (3 papers). The work is most often cited by research in Cancer Research (245 citations), Nephrology (46 citations) and Molecular Biology (405 citations). Eric P. van der Veer has collaborated with scholars based in Netherlands, United States and Australia. Frequent co-authors include Anton Jan van Zonneveld, Ton J. Rabelink, Ruben G. de Bruin, Roel Bijkerk, Coen van Solingen, Hetty C. de Boer, Jacques M.G.J. Duijs, Janine M. van Gils, Benjamin D. Humphreys and Paul H.A. Quax. Their work appears in journals such as Nucleic Acids Research, Biomaterials and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact